A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma

NCT03802071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Durvalumab+doxorubicin cobination

Sponsor

Yonsei University